EO9 Phase II Study in Advanced Breast, Gastric, Pancreatic and Colorectal Carcinoma by the EORTC Early Clinical Studies Group

European Journal of Cancer - United Kingdom
doi 10.1016/0959-8049(96)00226-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Docetaxel (TaxotereTM), a Novel Taxoid, in the Treatment of Advanced Colorectal Carcinoma: An EORTC Early Clinical Trials Group Study

British Journal of Cancer
Cancer ResearchOncology
1994English

A Phase II Study of Paclitaxel in Advanced Bronchioloalveolar Carcinoma (EORTC Trial 08956)

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2005English

Phase II Trial of UFT in Advanced Colorectal and Gastric Cancer

British Journal of Cancer
Cancer ResearchOncology
1990English

A Clinical Phase II Study of Sorafenib in Advanced Hepatocellular Carcinoma

Anaplastology
2012English

A Multi-Center Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2008English

A Clinical Study of Locally Advanced Carcinoma of Breast

Journal of Evidence Based Medicine and Healthcare
2015English

Phase II Study of Docetaxel and Irinotecan Combination Chemotherapy in Metastatic Gastric Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2006English

Gemcitabine and Oxaliplatin (GEMOX) in Gemcitabine Refractory Advanced Pancreatic Adenocarcinoma: A Phase II Study

British Journal of Cancer
Cancer ResearchOncology
2006English

Nab-Paclitaxel as Second-Line Treatment in Advanced Gastric Cancer: A Multicenter Phase II Study of the Hellenic Oncology Research Group

Annals of Gastroenterology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy